This commentary discusses the early licensing and deployment of a COVID-19 vaccine and how accomplishing this goal could compromise ethical principles that guide clinical research.
No takes yet. Share an insight, caveat, or question.
Dal‐Ré et al. (2020) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: